{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T04:07:23Z","timestamp":1744430843858,"version":"3.40.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,11]]},"DOI":"10.7759\/cureus.82060","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T09:43:11Z","timestamp":1744364591000},"source":"Crossref","is-referenced-by-count":0,"title":["Hypertensive Heart Disease in the Nigerian Population: Prevalence, Phenotypes, and Cardiovascular Comorbidities"],"prefix":"10.7759","author":[{"given":"Olugbenga O","family":"Abiodun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Anya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Salau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olalekan","family":"Ogunsakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Adekanmbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac393","article-title":"Phenotyping the hypertensive heart","volume":"43","author":"Tadic M","year":"2022","unstructured":"Tadic M, Cuspidi C, Marwick TH. Phenotyping the hypertensive heart. Eur Heart J. 2022, 43:3794-810. 10.1093\/eurheartj\/ehac393","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13271-0","article-title":"Global, regional, and national burden of hypertensive heart disease during 1990-2019: an analysis of the global burden of disease study 2019","volume":"22","author":"Lu Y","year":"2022","unstructured":"Lu Y, Lan T. Global, regional, and national burden of hypertensive heart disease during 1990-2019: an analysis of the global burden of disease study 2019. BMC Public Health. 2022, 22:841. 10.1186\/s12889-022-13271-0","journal-title":"BMC Public Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Mensah GA","year":"2023","unstructured":"Mensah GA, Fuster V, Murray CJ, Roth GA. Global burden of cardiovascular diseases and risks, 1990-2022. J Am Coll Cardiol. 2023, 82:2350-473. 10.1016\/j.jacc.2023.11.007","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy JW","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al.. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024, 45:3912-4018. 10.1093\/eurheartj\/ehae178","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner MH","year":"2011","unstructured":"Drazner MH. The progression of hypertensive heart disease. Circulation. 2011, 123:327-34. 10.1161\/CIRCULATIONAHA.108.845792","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-020-1017-9","article-title":"Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy","volume":"22","author":"Nwabuo CC","year":"2020","unstructured":"Nwabuo CC, Vasan RS. Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy. Curr Hypertens Rep. 2020, 22:11. 10.1007\/s11906-020-1017-9","journal-title":"Curr Hypertens Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12551-020-00738-w","article-title":"Imaging tools for assessment of myocardial fibrosis in humans: the need for greater detail","volume":"12","author":"Hassan S","year":"2020","unstructured":"Hassan S, Barrett CJ, Crossman DJ. Imaging tools for assessment of myocardial fibrosis in humans: the need for greater detail. Biophys Rev. 2020, 12:969-87. 10.1007\/s12551-020-00738-w","journal-title":"Biophys Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2011.104","article-title":"Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies","volume":"26","author":"Cuspidi C","year":"2012","unstructured":"Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012, 26:343-9. 10.1038\/jhh.2011.104","journal-title":"J Hum Hypertens"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60417-1","article-title":"Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study","volume":"371","author":"Sliwa K","year":"2008","unstructured":"Sliwa K, Wilkinson D, Hansen C, et al.. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet. 2008, 371:915-22. 10.1016\/S0140-6736(08)60417-1","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-6-4","article-title":"Left ventricular geometric patterns in newly presenting Nigerian hypertensives: an echocardiographic study","volume":"6","author":"Aje A","year":"2006","unstructured":"Aje A, Adebiyi AA, Oladapo OO, Dada A, Ogah OS, Ojji DB, Falase AO. Left ventricular geometric patterns in newly presenting Nigerian hypertensives: an echocardiographic study. BMC Cardiovasc Disord. 2006, 6:4. 10.1186\/1471-2261-6-4","journal-title":"BMC Cardiovasc Disord"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4137\/CMC.S12727","article-title":"Echocardiographic assessment of left ventricular geometric patterns in hypertensive patients in Nigeria","volume":"7","author":"Adebayo RA","year":"2013","unstructured":"Adebayo RA, Bamikole OJ, Balogun MO, et al.. Echocardiographic assessment of left ventricular geometric patterns in hypertensive patients in Nigeria. Clin Med Insights Cardiol. 2013, 7:161-7. 10.4137\/CMC.S12727","journal-title":"Clin Med Insights Cardiol"},{"key":"ref12","article-title":"Prevalence of left ventricular diastolic dysfunction in newly diagnosed Nigerians with systemic hypertension: a pulsed wave Doppler echocardiographic study","volume":"10","author":"Adamu GU","year":"2010","unstructured":"Adamu GU, Katibi AI, Opadijo GO, et al.. Prevalence of left ventricular diastolic dysfunction in newly diagnosed Nigerians with systemic hypertension: a pulsed wave Doppler echocardiographic study. Afr Health Sci. 2010, 10:177-82.","journal-title":"Afr Health Sci"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-017-3034-6","article-title":"A predominance of hypertensive heart disease among patients with cardiac disease in Buea, a semi-urban setting, South West Region of Cameroon","volume":"10","author":"Nkoke C","year":"2017","unstructured":"Nkoke C, Makoge C, Dzudie A, Mfeukeu LK, Luchuo EB, Menanga A, Kingue S. A predominance of hypertensive heart disease among patients with cardiac disease in Buea, a semi-urban setting, South West Region of Cameroon. BMC Res Notes. 2017, 10:684.","journal-title":"BMC Res Notes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.16483","article-title":"Worldwide trends in prevalence, mortality, and disability-adjusted life years for hypertensive heart disease from 1990 to 2017","volume":"77","author":"Dai H","year":"2021","unstructured":"Dai H, Bragazzi NL, Younis A, Zhong W, Liu X, Wu J, Grossman E. Worldwide trends in prevalence, mortality, and disability-adjusted life years for hypertensive heart disease from 1990 to 2017. Hypertension. 2021, 77:1223-33. 10.1161\/HYPERTENSIONAHA.120.16483","journal-title":"Hypertension"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang RM","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, et al.. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015, 28:1-39.e14. 10.1016\/j.echo.2014.10.003","journal-title":"J Am Soc Echocardiogr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of\u00a0Cardiovascular Imaging","volume":"29","author":"Nagueh SF","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, et al.. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of\u00a0Cardiovascular Imaging. J Am Soc Echocardiogr. 2016, 29:277-314. 10.1016\/j.echo.2016.01.011","journal-title":"J Am Soc Echocardiogr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022, 79:e263-421. 10.1016\/j.jacc.2021.12.012","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin c-based equations to estimate GFR without race","volume":"385","author":"Inker LA","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, et al.. New creatinine- and cystatin c-based equations to estimate GFR without race. N Engl J Med. 2021, 385:1737-49. 10.1056\/NEJMoa2102953","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti J","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, et al.. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020, 41:407-77. 10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer DO","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, et al.. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2021, 52:e364-467. 10.1161\/STR.0000000000000375","journal-title":"Stroke"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft061","article-title":"A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases","volume":"15","author":"Ojji D","year":"2013","unstructured":"Ojji D, Stewart S, Ajayi S, Manmak M, Sliwa K. A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: a prospective clinical registry of 1515 de novo cases. Eur J Heart Fail. 2013, 15:835-42. 10.1093\/eurjhf\/hft061","journal-title":"Eur J Heart Fail"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","author":"Lang RM","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, et al.. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18:1440-63. 10.1016\/j.echo.2005.10.005","journal-title":"J Am Soc Echocardiogr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000169972.96201.8e","article-title":"Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study","volume":"46","author":"Drazner MH","year":"2005","unstructured":"Drazner MH, Dries DL, Peshock RM, et al.. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension. 2005, 46:124-9. 10.1161\/01.HYP.0000169972.96201.8e","journal-title":"Hypertension"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3109\/08037051.2013.791415","article-title":"Prevalence and covariates of abnormal left ventricular geometry in never-treated hypertensive patients in Tanzania","volume":"23","author":"Chillo P","year":"2014","unstructured":"Chillo P, Lwakatare J, Rieck AE, Lutale J, Gerdts E. Prevalence and covariates of abnormal left ventricular geometry in never-treated hypertensive patients in Tanzania. Blood Press. 2014, 23:31-8. 10.3109\/08037051.2013.791415","journal-title":"Blood Press"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1067\/mje.2001.113258","article-title":"Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the Strong Heart Study","volume":"14","author":"Ilercil A","year":"2001","unstructured":"Ilercil A, O'Grady MJ, Roman MJ, et al.. Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: the Strong Heart Study. J Am Soc Echocardiogr. 2001, 14:601-11. 10.1067\/mje.2001.113258","journal-title":"J Am Soc Echocardiogr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy D","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990, 322:1561-6. 10.1056\/NEJM199005313222203","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101256","article-title":"Sex-related differences in left\u00a0ventricular geometry patterns in\u00a0patients with arterial hypertension","volume":"3","author":"Canciello G","year":"2024","unstructured":"Canciello G, Piccolo R, Izzo R, et al.. Sex-related differences in left\u00a0ventricular geometry patterns in\u00a0patients with arterial hypertension. JACC Adv. 2024, 3:101256. 10.1016\/j.jacadv.2024.101256","journal-title":"JACC Adv"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi019","article-title":"Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study","volume":"26","author":"de Simone G","year":"2005","unstructured":"de Simone G, Kitzman DW, Chinali M, et al.. Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study. Eur Heart J. 2005, 26:1039-45. 10.1093\/eurheartj\/ehi019","journal-title":"Eur Heart J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01360","article-title":"Long-term antihypertensive treatment fails to improve E\/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy","volume":"63","author":"Barron AJ","year":"2014","unstructured":"Barron AJ, Hughes AD, Sharp A, et al.. Long-term antihypertensive treatment fails to improve E\/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy. Hypertension. 2014, 63:252-8. 10.1161\/HYPERTENSIONAHA.113.01360","journal-title":"Hypertension"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/350868-hypertensive-heart-disease-in-the-nigerian-population-prevalence-phenotypes-and-cardiovascular-comorbidities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T09:43:13Z","timestamp":1744364593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/350868-hypertensive-heart-disease-in-the-nigerian-population-prevalence-phenotypes-and-cardiovascular-comorbidities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.82060","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,11]]}}}